Literature DB >> 33191095

Arecoline enhances miR-21 to promote buccal mucosal fibroblasts activation.

Hui-Wen Yang1, Cheng-Chia Yu2, Pei-Ling Hsieh3, Yi-Wen Liao4, Pei-Ming Chu3, Chuan-Hang Yu5, Chih-Yuan Fang6.   

Abstract

BACKGROUND/
PURPOSE: Oral submucous fibrosis (OSF) is an irreversible fibrosis disease and a potentially malignant disorder in the oral cavity. Various studies have shown that miR-21 was implicated in the fibrogenesis and carcinogenesis, but its functional role in the development of OSF has not been investigated.
METHODS: The expression levels of miR-21 in arecoline-stimulated normal buccal mucosal fibroblasts (BMFs) and OSF specimens were determined by qRT-PCR. Exogenous administration of TGF-β and its inhibitor (SB431542) were utilized to examine the involvement of TGF-β signaling in miR-21 alteration. Collagen gel contraction, transwell migration, and invasion assays were used to assess the myofibroblast activities. The relationship between α-SMA and miR-21 was calculated using the Pearson correlation coefficient.
RESULTS: MiR-21 expression was induced in BMFs by arecoline treatment in a dose-dependent manner. Our results showed that this upregulation was mediated by TGF-β signaling. Subsequently, we demonstrated that the administration of the miR-21 inhibitor suppressed the arecoline-induced myofibroblast characteristics, including a higher collagen gel contractility and cell motility, in normal BMFs. Furthermore, inhibition of miR-21 was sufficient to attenuate the myofibroblast features in fibrotic BMFs. Besides, we showed that the expression of miR-21 was aberrantly upregulated in the OSF tissues and there was a positive correlation between miR-21 and myofibroblast marker, α-SMA.
CONCLUSION: MiR-21 overexpression in OSF may be due to the stimulation of areca nut, which was mediated by the TGF-β pathway. Our data suggested that the repression of miR-21 was a promising direction to palliate the development and progression of OSF.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  MicroRNA-21; Myofibroblast; Oral submucous fibrosis; TGF-β pathway

Year:  2020        PMID: 33191095     DOI: 10.1016/j.jfma.2020.10.019

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  6 in total

1.  Knockdown of LncRNA NEAT1 inhibits myofibroblast activity in oral submucous fibrosis through miR-760/TPM1 axis.

Authors:  Wei Li; Bin Cheng
Journal:  J Dent Sci       Date:  2021-12-08       Impact factor: 3.719

2.  miR-21 promotes the fibrotic properties in oral mucosa through targeting PDCD4.

Authors:  Yi-Wen Liao; Lo-Lin Tsai; Yu-Hsien Lee; Pei-Ling Hsieh; Cheng-Chia Yu; Ming-Yi Lu
Journal:  J Dent Sci       Date:  2021-09-15       Impact factor: 3.719

3.  miR-509 inhibits cancer stemness properties in oral carcinomas via directly targeting PlK1.

Authors:  Ming-Yi Lu; Chih-Yuan Fang; Pei-Ling Hsieh; Yi-Wen Liao; Lo-Lin Tsai; Cheng-Chia Yu
Journal:  J Dent Sci       Date:  2021-10-08       Impact factor: 3.719

4.  microRNA-1266-5p directly targets DAB2IP to enhance oncogenicity and metastasis in oral cancer.

Authors:  Chih-Yu Peng; Che-Yi Lin; Szu-Han Chen; Yi-Wen Liao; Cheng-Chia Yu; Shiao-Pieng Lee
Journal:  J Dent Sci       Date:  2021-11-26       Impact factor: 3.719

Review 5.  The functional roles of microRNAs in the pathogenesis of oral submucous fibrosis.

Authors:  Pei-Ling Hsieh; Szu-Han Chen; Yu-Feng Huang; Ming-Yi Lu; Cheng-Chia Yu
Journal:  J Dent Sci       Date:  2021-08-01       Impact factor: 3.719

6.  The upregulation of oncogenic miRNAs in swabbed samples obtained from oral premalignant and malignant lesions.

Authors:  Shu-Chun Lin; Chung-Ji Liu; Si-Hua Ji; Wan-Wen Hung; Ying-Chieh Liu; Sih-Rou Chang; Hsi-Feng Tu; Kuo-Wei Chang
Journal:  Clin Oral Investig       Date:  2021-08-03       Impact factor: 3.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.